Evolution Of Lipid Management Portfolio Positions Abbott Laboratories As A Leader In The Lucrative Dyslipidemia Market
Newly released report, Abbott Laboratories: PharmaVitae Profile, provides detailed company analysis
Published on November 10, 2009
by Press Office
(Companiesandmarkets.com and OfficialWire)
LONDON, ENGLAND
This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
*Benchmark Abbott's performance against key rivals in the prescription pharmaceutical sector
*Discover how Abbott has utilised M&A to become one of the worlds largest multi-disciplinary healthcare companies
*Investigate the strategies being employed by Abbott to overcome an under strength pipeline and various litigation proceedings
The Affordable Business Wire of Choice For PR Professionals ™
OfficialWire was founded April 24, 2001 — Follow Us @OfficialWire Journalist Registration — Earn money with OfficialWire — Join our Affiliate Program. Meet our Media Partners.
To advertise on OfficialWire simply register and upload your ad using our automated ad server.
This service is provided subject to OfficialWire's standard Terms and Conditions. Please read our Privacy Policy. OfficialWire®, Give Good PR ™, Be The News...™ & The Affordable Business Wire of Choice For PR Professionals ™ are trademarks owned by Greg Smith — OfficialWire, ISSN: 1550-1531, is continuously published by Greg Smith Compare OfficialWire to other press release distribution services — Testimonials
—
